Evropská unie -
čeština -
EMA (European Medicines Agency)
voraxaze
serb sas - glucarpidase - metabolic side effects of drugs and substances - všechny ostatní terapeutické přípravky - voraxaze is indicated to reduce toxic plasma methotrexate concentration in adults and children (aged 28 days and older) with delayed methotrexate elimination or at risk of methotrexate toxicity.
Evropská unie -
čeština -
EMA (European Medicines Agency)
briumvi
neuraxpharm pharmaceuticals s.l. - ublituximab - multiple sclerosis, relapsing-remitting; multiple sclerosis - imunosupresiva - briumvi is indicated for the treatment of adult patients with relapsing forms of multiple sclerosis (rms) with active disease defined by clinical or imaging features.
Česká republika -
čeština -
USKVBL (Ústav Pro Státní Kontrolu Veterinárních Biopreparátů A Léčiv)
stomorgyl 20 potahovaná tableta
boehringer ingelheim animal health france scs - spiramycinu a metronidazolu - potahovaná tableta - 20 - kombinace antibakteriální - psi